FDMT vs ICE · rev $37.0K vs P/E 37, rev $12.64B
4D Molecular Therapeutics Inc (FDMT) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
FDMT currently screens at market cap $518.1M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the FDMT and ICE stock pages for the full models.
Not investment advice.